The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
Giuseppe Murdolo, Ulf Smith

Abstract

An emerging paradigm supports the view that adipose tissue (AT) dysregulation might play a crucial role in the pathogenesis of insulin-resistance and atherosclerosis. The net result of such a dysregulation is a state of low-grade, chronic, systemic inflammation that, in turn, links both the metabolic and the vascular pathologies. Overwhelming evidence shows that high circulating levels of markers of chronic inflammation predict the development of T2DM and atherosclerotic manifestations. Therefore, atherosclerotic cardiovascular disease and T2DM seem to arise from a "common soil", and chronic inflammation is a candidate. In this scenario, the dysfunctional AT provide a common hallmark for these apparently divergent disorders. An important question then is whether dysregulated and inflamed AT can be converted to healthy fat and, consequently, the development or the progression of metabolic and vascular impairment can be prevented or reversed by the modulation of the inflammatory profile. The beneficial effects of weight loss on obesity-related complications are clearly associated with the modification of the inflammatory profile in the AT. Furthermore, the thiazolidinediones (TZDs) possess both anti-inflammatory and anti-atheroge...Continue Reading

References

May 1, 1995·The Journal of Clinical Investigation·G S HotamisligilB M Spiegelman
Dec 1, 1995·Journal of Internal Medicine·T Yokota, G K Hansson
Oct 30, 1998·Diabetologia·J C Pickup, M A Crook
Mar 10, 2001·The Journal of Clinical Endocrinology and Metabolism·J M BruunB Richelsen
Apr 28, 2001·Molecular and Cellular Endocrinology·C C GerhardtA D Strosberg
Feb 6, 2002·Circulation·André TchernofEric T Poehlman
Nov 26, 2002·Nature·Jiro HirosumiGökhan S Hotamisligil
Jan 10, 2003·The Journal of Biological Chemistry·Guillaume CharrièreLouis Casteilla
May 9, 2003·American Journal of Physiology. Endocrinology and Metabolism·Jens M BruunBjorn Richelsen
Oct 1, 2003·Circulation·Muredach P Reilly, Daniel J Rader
Dec 18, 2003·The Journal of Clinical Investigation·Stuart P WeisbergAnthony W Ferrante
Mar 30, 2004·Diabetes·Menotti CalvaniGeltrude Mingrone
Apr 20, 2004·Biochemical and Biophysical Research Communications·Xiaolin YangUlf Smith
Oct 28, 2004·The Journal of Clinical Endocrinology and Metabolism·Luis Alberto VázquezJosé Antonio Amado
Aug 2, 2005·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Tiny HoekstraCornelis Kluft

❮ Previous
Next ❯

Citations

Jan 29, 2008·Journal of Clinical Immunology·Krystallenia I AlexandrakiAnastasios Kalofoutis
Jan 3, 2014·International Journal of Rheumatic Diseases·Aman SharmaSunil Dogra
Apr 17, 2009·Cardiovascular Diabetology·Omar S Al-AttasAlison L Harte
Aug 24, 2006·American Journal of Physiology. Endocrinology and Metabolism·Carey N LumengAlan R Saltiel
May 24, 2011·Acta Diabetologica·Soumaya KouidhiAmel Benammar Elgaaied
Jun 12, 2009·Gender Medicine·Ronald Tamler
Nov 18, 2008·Metabolism: Clinical and Experimental·Hong LiErik Michaëlsson
Jul 8, 2008·European Journal of Pharmacology·Mingxue ZhouKeji Chen
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Brian G Choi, Mary Ann McLaughlin
Apr 3, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Claudio PaganoRoberto Vettor
Oct 13, 2009·The Journal of Clinical Hypertension·Samy I McFarlane
Jul 25, 2007·Journal of Internal Medicine·P-A Jansson
Dec 8, 2006·Annals of the New York Academy of Sciences·Krystallenia AlexandrakiAnastasios Kalofoutis
Aug 15, 2006·Pathologie-biologie·T FulopA Carpentier
Mar 14, 2013·BioMed Research International·Panayoula C TsiotraSotirios A Raptis
Aug 21, 2013·Free Radical Biology & Medicine·Giuseppe MurdoloFrancesco Galli
Nov 27, 2009·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Anirban Basu
Jan 17, 2007·Current Opinion in Pediatrics·Jorge A AlvarezSteven E Lipshultz
Aug 15, 2014·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Giuseppe MurdoloPaolo Vedecchia
Oct 7, 2016·The Journal of Clinical Endocrinology and Metabolism·Giuseppe MurdoloFrancesco Galli
Jul 24, 2014·Angiology·Edita StokićEsma R Isenovic
Oct 13, 2018·Molecular Biology Reports·Krishnamoorthy Vijayalakshmi, Chinnadurai Immanuel Selvaraj
Jun 15, 2019·International Journal of Molecular Sciences·Shubhangi ChauhanLawrence K Duffy
Mar 21, 2017·European Journal of Nutrition·Esther María González-GilUNKNOWN IDEFICS Consortium
Jul 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tracie L MillerSteven E Lipshultz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.